The aims of this systematic review are to evaluate studies concerning the cost-effectiveness analysis of TDM of anti-TNF in IBD and to provide a critical analysis of the best scientific knowledge available on the use of TDM. This evidence concerns the gene TNF and inflammatory bowel disease.